Search results
Results will auto-populate based on filter selection.
results found
661
Found 661 result(s)
You can also read…
Faster. Online. Anytime. WSIB’s online services are available 24/7, whenever you need them. They’re quick and efficient…
On this page:Key principlesDefinitionsImpairmentIntroduction…
You can ensure you receive your WSIB benefit payments quickly and efficiently by using the WSIB’s direct deposit services.Direct deposit is a fast, safe and easy way to…
You can use a third-party representative to provide advice and help you interact with us. Authorized representatives can receive verbal or written information from us about…
Our records
We keep records ranging from corporate information to reference material to personal information, which are described below in the Directory…
General records:
Internal and External Policy Advice
Occupational Disease Scientific Reviews and Opinions
Policy Development – Original Approved Policies
Policy…
Update July 26, 2023
The first phase of our consultation began on June 8, 2023 and closed on July 21, 2023. We appreciate all the feedback received, which overwhelmingly…
Each year, we are required under the Workplace Safety and Insurance Act to conduct a value-for-money audit. The latest audit focused on the dispute resolution, appeals and…
Most Ontario businesses that have employees (including family members and sub-contractors) must register with us. We provide workplace insurance to 16 diverse industries and…
On this page:
1. Introduction
1.1. Background
2. Occupational disease legislative and policy scheme…
The Drug Advisory Committee was established in 2007 to guide WSIB on which drugs to include in our drug benefit plan as well as the medical conditions and criteria needed for…
Each year, we are required under the Workplace Safety and Insurance Act (WSIA) to have an external firm review the cost, efficiency, and effectiveness of one of our programs…
Onabotulinumtoxin-A, incobotulinumtoxin-A, abobotulinumtoxin-A
Indication(s)
OnabotulinumtoxinA (Botox®) is indicated for the treatment of blepharospasm/VII…
Buprenorphine/naloxone (SL), buprenorphine subdermal implant and buprenorphine extended-release (ER) injection
Indication(s)
Buprenorphine/naloxone sublingual (SL) tablet (…
Indication
Prevention of migraine in adults who have at least four migraine days per month.
Formulary Status
The WSIB Drug Advisory Committee (DAC) recommended that…
Corticosteroid injections in musculoskeletal conditions
Indications/Clinical uses
Treatment of acute and chronic musculoskeletal conditions including neck and upper…
Toronto, November 25, 2020 - The WSIB is pleased to announce that Elizabeth Witmer has been reappointed Chair of the Board of Directors of Ontario’s WSIB for a fourth term…
Toronto, May 19, 2020 – The WSIB is pleased to announce that Elizabeth Witmer has been reappointed Chair of the Board of Directors of Ontario’s WSIB for a third term. …
AudioVisualUpbeat, inspiring background music is playingWSIB logoAmirah’s voice says: Innovation plays a really large role in the WSIB.Three people are congregating outside a…